期刊
MARINE DRUGS
卷 18, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/md18060327
关键词
diterpenoids; dendrillins; malaria; leishmaniasis; MRSA biofilm
资金
- Nation Science Foundation from the Antarctic Organisms and Ecosystems Program [PLR-1341333, PLR-1341339]
- NIH [AI103673, AI103715, AI124458]
- State of Florida for Center of Excellence funding of the Center for Drug Discovery and Innovation
The Antarctic spongeDendrilla antarcticais rich in defensive terpenoids with promising antimicrobial potential. Investigation of this demosponge has resulted in the generation of a small chemical library containing diterpenoid secondary metabolites with bioactivity in an infectious disease screening campaign focused onLeishmania donovani,Plasmodium falciparum, and methicillin-resistantStaphylococcus aureus(MRSA) biofilm. In total, eleven natural products were isolated, including three new compounds designated dendrillins B-D (10-12). Chemical modification of abundant natural products led to three semisynthetic derivatives (13-15), which were also screened. Several compounds showed potency against the leishmaniasis parasite, with the natural products tetrahydroaplysulphurin-1 (4) and dendrillin B (10), as well as the semisynthetic triol15, displaying single-digit micromolar activity and low mammalian cytotoxicity. Triol15displayed the best profile against the liver-stage malaria parasites, while membranolide (5) and dendrillin C (11) were strong hits against MRSA biofilm cultures.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据